Key Takeaways COIN Q2 EPS fell 88.8% Y/Y to $0.12, missing estimates by nearly 90% despite volume and price gains.Total revenues rose 3.2% Y/Y on higher subscription, service and other income despite lower transactions.Expenses surged 37.5% Y/Y to $1.5B, weighing on adjusted EBITDA, which dipped 3.2% to $512M.Coinbase Global, Inc. (COIN) reported second-quarter 2025 net operating earnings per share of 12 cents, which missed the Zacks Consensus Estimate by 89.9%. The bottom line decreased 88.8% year over yea ...

Key Takeaways CFR posted Q2 EPS of $2.39, increasing 8.1% y/y and beating estimates by 4.8%.Revenues rose 7.4% to $567.8M, led by growth in net interest and non-interest income.Shares fell as expenses climbed 9.5% and the higher allowance for credit losses on loans remained concerning.Cullen/Frost Bankers, Inc. (CFR) reported second-quarter 2025 earnings per share of $2.39, up 8.1% from the prior-year quarter. The bottom line surpassed the Zacks Consensus Estimate by 4.8%.Results were primarily aided by a r ...

Key Takeaways SMCI's Server and Storage Systems segment is fueled by hyperscaler, AI, and HPC demand.Early availability of NVIDIA Blackwell and strong DLC adoption boosted data center traction.Margins remain pressured by customer mix, pricing, and costs tied to DLC AI GPU clusters.Super Micro Computer (SMCI) is set to report its fourth-quarter fiscal 2025 results on Aug. 5. Investor attention is firmly focused on the company’s server and storage business, which is driven by robust traction from hyperscalers ...

Key Takeaways OPK posted a Q2 loss of 19 cents per share, missing estimates and widening from a loss of a penny a year ago.OPKO Health's Q2 revenue fell 13.9% year over year to $156.8 million due to lower diagnostics service sales.OPKO Health's gross margin rose 315 bps to 31.5% as product sales held steady and SG&A costs declined.OPKO Health, Inc. (OPK) delivered a loss per share of 19 cents in the second quarter of 2025, wider than the year-ago period’s loss of a penny per share and the Zacks Consensus Es ...

Investors might want to bet on Kiniksa Pharmaceuticals International, plc (KNSA) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a stro ...

Newmark Group (NMRK) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this provider of commercial real estate services is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation betw ...

Materion (MTRN) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this supplier of engineered materials to technology companies is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlat ...

Mastercard Inc. MA reported stronger-than-expected second-quarter results on Thursday, prompting a wave of upward revisions from Wall Street analysts who cited accelerating growth in value-added services (VAS) and solid international volume trends as key drivers of future performance.The payments giant reported adjusted revenue of $8.13 billion and earnings per share of $4.15, beating consensus estimates. Total net revenue rose 16% year-over-year, while VAS revenue climbed 23% on a reported basis and 22% in ...

SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On July 25, 2025, investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares significantly fall during intraday trading on reports that U.S. lawmakers urged the FDA to act against copycat versions of weight loss drugs, citing safety concerns. This latest development follows an announcement by Novo Nordisk on June 23, 2025, the Danish maker of the FDA-approved weight-loss medication Wegovy® (a GLP-1 treatment for obesity), that it termina ...

Arc Resources Ltd. (OTCPK:AETUF) Q2 2025 Earnings Call August 1, 2025 10:00 AM ET Company Participants Armin Jahangiri - Senior VP & COO Dale Lewko - Manager of Capital Markets Kristen J. Bibby - Senior VP & CFO Ryan Victor Berrett - Senior Vice President of Marketing Terry Michael Anderson - President, CEO & Director Conference Call Participants Aaron Bilkoski - TD Cowen, Research Division James Kubik - CIBC Capital Markets, Research Division Kaleinoheaokealaula Scott Akamine - BofA Securities, Research Di ...